Skip to main content
. 2021 Mar 19;12(10):3067–3076. doi: 10.7150/jca.54759

Figure 1.

Figure 1

Expression of miR-369 is downregulated in liver fibrosis and liver cancer tissues. A. Real-time PCR analysis of miR-369 in patient fibrotic tissues (n=20) or normal tissues (n=10) from liver (p<0.05). B. Real-time PCR analysis of miR-369 in CCL4-induced fibrosis mice (n=8) (p<0.05). C. Real-time PCR analysis of miR-369 in BDL-induced fibrosis mice (n=8) (p<0.05). D. The expression of miR-369 in human liver cancer patients' tissues and their corresponding adjacent normal tissues (n=20) was checked by real-time PCR analysis (p<0.05). E. The expression of miR-369 in adjacent normal tissues, liver cancer tissues and their corresponding metastasis tissues (n=12) was checked by real-time PCR analysis (p<0.05). F. The expression of miR-369 in primary liver cancer tissues and recurrence liver cancer tissues was investigated via real-time PCR analysis (n=15) (p<0.05) (Data are presented as mean ± SEM).